$90.32
-0.69-0.76%
In chiusura: -
$90.32
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
ANI Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 7
Stima EPS
$1.537
Stima dei ricavi trimestrali
$193.24M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$747.40M
Analizza lo storico degli utili di ANI Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ANIP | ANI Pharmaceuticals | $1.34 | $1.54 | — | — | $148.33M | $193.24M | — | — | 11/07/2025 | |
ANIP | ANI Pharmaceuticals | $1.02 | $1.39 | $1.80 | 42.86% | $138.04M | $187.80M | $211.37M | 11.60% | 08/08/2025 | |
ANIP | ANI Pharmaceuticals | $1.21 | $1.38 | $1.70 | 2933.33% | $137.43M | $180.68M | $197.12M | 9.09% | 05/09/2025 | |
ANIP | ANI Pharmaceuticals | $1.00 | $1.44 | $1.63 | 462.07% | $131.65M | $175.37M | $190.57M | 8.68% | 02/28/2025 | |
ANIP | ANI Pharmaceuticals | $1.27 | $1.09 | $1.34 | 22.94% | $131.83M | $144.35M | $148.33M | 2.76% | 11/08/2024 | |
ANIP | ANI Pharmaceuticals | $1.28 | $0.95 | $1.02 | 8.51% | $116.55M | $129.05M | $138.04M | 7.32% | 08/06/2024 | |
ANIP | ANI Pharmaceuticals | $1.17 | $0.99 | $1.21 | 22.22% | $106.79M | $125.52M | $137.43M | 9.49% | 05/10/2024 | |
ANIP | ANI Pharmaceuticals | $0.76 | $1.41 | $1.00 | 17.65% | $94.23M | $185.12M | $131.65M | 7.73% | 02/29/2024 | |
ANIP | ANI Pharmaceuticals | $0.64 | $1.32 | $1.27 | 51.19% | $83.82M | $175.92M | $131.83M | 17.79% | 11/08/2023 | |
ANIP | ANI Pharmaceuticals | $0.13 | $1.11 | $1.28 | 88.24% | $73.86M | $165.34M | $116.55M | 18.08% | 08/09/2023 | |
ANIP | ANI Pharmaceuticals | -$0.12 | $1.45 | $1.17 | 234.29% | $64.48M | $175.08M | $106.79M | 27.90% | 05/08/2023 | |
ANIP | ANI Pharmaceuticals | $0.54 | $0.67 | $0.76 | 13.43% | $60.93M | $86.14M | $94.23M | 9.39% | 03/09/2023 | |
ANIP | ANI Pharmaceuticals | $1.01 | $0.55 | $0.64 | 16.36% | $52.06M | $78.16M | $83.82M | 7.24% | 11/09/2022 | |
ANIP | ANI Pharmaceuticals | $0.67 | $0.22 | $0.13 | -40.91% | $48.63M | $72.10M | $73.86M | 2.43% | 08/08/2022 | |
ANIP | ANI Pharmaceuticals | $1.04 | $0.09 | -$0.12 | -233.33% | $54.52M | $65.03M | $64.48M | -0.85% | 05/10/2022 | |
ANIP | ANI Pharmaceuticals | $0.80 | $0.74 | $0.54 | -27.03% | $57.25M | $56.30M | $60.93M | 8.22% | 03/15/2022 | |
ANIP | ANI Pharmaceuticals | $0.97 | $0.70 | $1.01 | 44.29% | $52.98M | $49.70M | $52.06M | 4.75% | 11/01/2021 | |
ANIP | ANI Pharmaceuticals | $0.69 | $0.68 | $0.67 | -1.47% | $48.47M | $48.05M | $48.63M | 1.20% | 08/06/2021 | |
ANIP | ANI Pharmaceuticals | $1.04 | $0.71 | $1.04 | 46.48% | $49.77M | $46.80M | $54.52M | 16.50% | 05/07/2021 | |
ANIP | ANI Pharmaceuticals | $1.08 | $0.94 | $0.80 | -14.89% | $47.97M | $54.27M | $57.25M | 5.49% | 03/09/2021 | |
ANIP | ANI Pharmaceuticals | $1.23 | $0.88 | $0.97 | 10.23% | $51.34M | $51.50M | $52.98M | 2.87% | 11/05/2020 |
ANI Pharmaceuticals (ANIP) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $1.80 | $1.39 | 42.9 % |
| Q1 | 2025-05-09 | $1.70 | $1.38 | 2933.3 % |
| Q4 | 2025-02-28 | $1.63 | $1.44 | 462.1 % |
| Q3 | 2024-11-08 | $1.34 | $1.09 | 22.9 % |
ANI Pharmaceuticals (ANIP) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-08 | $211.37M | $187.80M | 11.6 % |
| Q1 | 2025-05-09 | $197.12M | $180.68M | 9.09 % |
| Q4 | 2025-02-28 | $190.57M | $175.37M | 8.68 % |
| Q3 | 2024-11-08 | $148.33M | $144.35M | 2.76 % |
FAQ
Quando ANI Pharmaceuticals (NASDAQ:ANIP) riporterà gli utili?
Si prevede che ANI Pharmaceuticals (ANIP) fornisca risultati il novembre 7, 2025. Gli ultimi risultati sono stati pubblicati il agosto 8, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di ANI Pharmaceuticals (NASDAQ:ANIP)?
L'EPS effettivo era $1.80, che superato la stima di $1.39.
Quali sono state le entrate di ANI Pharmaceuticals (NASDAQ:ANIP)?
Le entrate effettive sono state $211.4M, che superato la stima di $187.8M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.